Your browser doesn't support javascript.
loading
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
Hurvitz, Sara A; Martin, Miguel; Jung, Kyung Hae; Huang, Chiun-Sheng; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-François; Fasching, Peter A; Afenjar, Karen; Spera, Gonzalo; Lopez-Valverde, Vanesa; Song, Chunyan; Trask, Peter; Boulet, Thomas; Sparano, Joseph A; Symmans, W Fraser; Thompson, Alastair M; Slamon, Dennis.
Afiliación
  • Hurvitz SA; University of California, Los Angeles, Los Angeles, CA.
  • Martin M; Universidad Complutense, CUBERONC, GEICAM, Madrid, Spain.
  • Jung KH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Huang CS; National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Republic of China.
  • Harbeck N; University of Munich, Munich, Germany.
  • Valero V; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Stroyakovskiy D; Moscow City Oncology Hospital 62, Moscow, Russia.
  • Wildiers H; University Hospitals Leuven, Leuven, Belgium.
  • Campone M; Centre René Gauducheau, Saint-Herblain, France.
  • Boileau JF; McGill University, Jewish General Hospital Segal Cancer Centre, Montréal, Québec, Canada.
  • Fasching PA; University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Afenjar K; Translational Research in Oncology, Paris, France.
  • Spera G; Translational Research in Oncology, Montevideo, Uruguay.
  • Lopez-Valverde V; PAREXEL International GmbH, Berlin, Germany.
  • Song C; Genentech, South San Francisco, CA.
  • Trask P; Genentech, South San Francisco, CA.
  • Boulet T; PAREXEL International GmbH, Berlin, Germany.
  • Sparano JA; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY.
  • Symmans WF; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Thompson AM; Baylor College of Medicine, Houston, TX.
  • Slamon D; University of California, Los Angeles, Los Angeles, CA.
J Clin Oncol ; 37(25): 2206-2216, 2019 09 01.
Article en En | MEDLINE | ID: mdl-31157583
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Clin Oncol Año: 2019 Tipo del documento: Article País de afiliación: Canadá